1 Patent
- US118734862024Modulating Dsrna Editing, Sensing, and Metabolism to Increase Tumor Immunity and Improve the Efficacy of Cancer Immunotherapy And/or Modulators of Intratumoral Interferon
Dana-farber Cancer Institute, Inc.
0 cites
Dana-farber Cancer Institute, Inc.